Falling Biotechnology Stocks at NASDAQ: (EXEL, AMLN, ARNA, ZLCS, DNDN)
Exelixis, Inc. (NASDAQ:EXEL) dropped by 3.05% and closed at $11.12 whereas overall traded volume stood at 1.12 million shares for the day. The current market price is 5.21% more than its last 50 days simple moving average. The share price is likely to move by 1.78 times against 1 point change in market index.
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) plunged by 2.79% to close at $11.15 with total traded volume of 1.37 million shares in the last trading day. Its outstanding shares stood at 144.43 million. Its total market capitalization arrived at $1.61 billion.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $1.35 after moving down by 2.17% whereas traded volume stood at 4.86 million shares for the day as compare to its average volume stood at 2.99 million. The company maintains strong short term liquidity position with current ratio of 4.25 times.
Zalicus, Inc. (NASDAQ:ZLCS) witnessed the correction of 2.05% to close at $2.39 with overall traded volume of 1.36 million shares in the last trading day. The current market price is 11.33% more than its last 50 days simple moving average. The RSI value of 61.44 times depicts that the current share value is in overbought level.
Dendreon Corporation (NASDAQ:DNDN) reported the fall of 1.44% and closed at $36.87 whereas total traded volume stood at 3.09 million shares for the day. The share price is highly reactive to market index as its beta value stands at 3.59 times till its last trading session.